Aldo Bernasconi

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States
  Value in Health 2025 DOI: 10.1016/j.jval.2025.07.005
  +Save
• Omega-3 world map: 2024 update.
  Progress in lipid research 2024 DOI: 10.1016/j.plipres.2024.101286
  +Save
• Bringing the Potential Benefits of Omega-3 to a Higher Level.
  Mayo Clinic proceedings 2024 DOI: 10.1016/j.mayocp.2024.02.015
  +Save
• Development of a novel database to review and assess the clinical effects of EPA and DHA omega-3 fatty acids.
  Prostaglandins, leukotrienes, and essential fatty acids 2022 DOI: 10.1016/j.plefa.2022.102458
  +Save
• Impressive results with EPA, but EPA/DHA combinations also reduce cardiovascular outcomes.
  Progress in cardiovascular diseases 2021 DOI: 10.1016/j.pcad.2021.11.002
  +Save
• Omega-3 Benefits Remain Strong Post-STRENGTH
  Mayo Clinic Proceedings 2021 DOI: 10.1016/j.mayocp.2021.03.004
  +Save
• In Reply-Impact of a High-Shrimp Diet on Cardiovascular Risk: An NHANES Analysis.
  Mayo Clinic proceedings 2021 DOI: 10.1016/j.mayocp.2020.10.028
  +Save
• Effect of Omega-3 Dosage on Cardiovascular Outcomes
  Mayo Clinic Proceedings 2021 DOI: 10.1016/j.mayocp.2020.08.034
  +Save
• Predicting the effects of supplemental EPA and DHA on the omega-3 index.
  The American journal of clinical nutrition 2019 DOI: 10.1093/ajcn/nqz161
  +Save
• Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014.
  Prostaglandins, leukotrienes, and essential fatty acids 2016 DOI: 10.1016/j.plefa.2016.01.003
  +Save